Experimental and Therapeutic Medicine · 2014 · 35 citations · 22 references
MedicineInternal MedicineDiabetologyNeuropathologyOcular DiseaseDiabetes MellitusDiabetic NephropathyDiabetic NeuropathyDiabetic RetinopathyDiabetic Retinopathy EpidemiologyMetabolic SyndromeBlood PressureDiabetes-related ComplicationsDiabetic Retinopathy PrevalenceDisease Duration
The aim of this study was to investigate the association between diabetes mellitus (DM), mainly type II, with metabolic syndrome (MS) and diabetic nephropathy (DN)/diabetic retinopathy (DR). Based on the analysis of the prevalence of MS, patients with DM were divided into MS and non-MS groups according to the presence or absence of MS. The correlation between DN, DR and certain factors, including gender, age, disease duration and the presence or absence of a family history of MS, were analyzed. The prevalence of MS among the patients with DM was 62.50%. The prevalence of DN was 55.33% in the MS group and that of DR was 26.00%. DN was positively correlated with age, gender, blood pressure, triglyceride (TG), low-density lipoprotein cholesterol (LDL-C) and blood uric acid. DR was positively correlated with traceable disease duration and LDL-C. In conclusion, DM occurred more frequently in concurrence with MS than without MS, and the prevalence of DN/DR in the MS group was higher than that in the non-MS group. Age, gender, blood pressure, TG, LDL-C and blood uric acid were risk factors for DN and the traceable disease duration and LDL-C were risk factors for DR.
22
R. C. Turner, Charles Fox, Matthews et al. · The Lancet · 1998 · 8.4K citations
Prevalence of the Metabolic Syndrome Among US Adults
Earl S. Ford, Wayne H. Giles, William H. Dietz · JAMA · 2002 · 6.7K citations